Trans-stimulation effects of folic acid derivatives on methotrexate transport by rat renal organic anion transporter, OAT-K1

Journal of Pharmacology and Experimental Therapeutics

Volumn 293, Issue 3, 2000, Pages 1034-1039

  Takeuchi, Ayako ^a   Masuda, Satohiro ^a   Saito, Hideyuki ^a   Hashimoto, Yukiya ^a   Inui, Ken Ichi ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; AMINOPTERIN; BROMSULFOPHTHALEIN; CARRIER PROTEIN; FOLIC ACID; FOLIC ACID DERIVATIVE; FOLINATE CALCIUM; FOLINIC ACID; GLUTATHIONE; METHOTREXATE; OAT K1 PROTEIN; TAUROCHOLIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANION TRANSPORT; ARTICLE; CONTROLLED STUDY; DOG; DRUG EXCRETION; DRUG TRANSPORT; KIDNEY CELL; KIDNEY TUBULE EPITHELIUM; NONHUMAN; PRIORITY JOURNAL; RAT; SOLID TUMOR;

AMINOPTERIN; ANIMALS; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; CELL LINE; DOGS; FOLIC ACID; FOLIC ACID ANTAGONISTS; KIDNEY; LEUCOVORIN; MEMBRANE PROTEINS; METHOTREXATE; ORGANIC ANION TRANSPORTERS; RATS;

EID: 0034089653     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Abe T, Kakyo M, Sakagami H, Tokui T, Nishio T, Tanemoto M, Nomura H, Hebert SC, Matsuno S, Kondo H and Yawo H (1998) Molecular characterization and tissue distribution of a new organic anion transporter subtype (oatp3) that transports thyroid hormones and taurocholate and comparison with oatp2. J Biol Chem 273:22395-22401.
2. Bergwerk AJ, Shi X, Ford AC, Kanai N, Jacquemin E, Burk RD, Bai S, Novikoff PM, Stieger B, Meier PJ, Schuster VL and Wolkoff AW (1996) Immunologic distribution of an organic transport protein in rat liver and kidney. Am J Physiol 271: G231-G238.
3. Bischoff KB, Dedrick RL, Zaharko DS and Longstreth JA (1971) Methotrexate pharmacokinetics. J Pharm Sci 60:1128-1133.
4. Bleyer WA (1978) The clinical pharmacology of methotrexate: New applications of an old drug. Cancer 41:36-51.
5. Bourke RS, Chheda G, Bremer A, Watanabe O and Tower DB (1975) Inhibition of renal tubular transport of methotrexate by probenecid. Cancer Res 35:110-116.
6. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
7. Chan BS, Satriano JA, Pucci M and Schuster VL (1998) Mechanism of prostaglandin E2 transport across the plasma membrane of HeLa cells and Xenopus oocytes expressing the prostaglandin transporter "PGT". J Biol Chem 273:6689-6697.
8. Frei Ed, Blum RH, Pitman SW, Kirkwood JM, Henderson IC, Skarin AT, Mayer RJ, Bast RC, Garnick MB, Parker LM and Canellos GP (1980) High dose methotrexate with leucovorin rescue. Rationale and spectrum of antitumor activity. Am J Med 68:370-376.
9. Goldman ID (1971) A model system for the study of heteroexchange diffusion: Methotrexate-folic acid interactions in L1210 leukemia and Ehrlich ascites tumor cells. Biochim Biophys Acta 233:624-634.
10. He YL, Tanigawara Y, Yasuhara M and Hori R (1991) Effect of folinic acid on tissue residence and excretion of methotrexate in rats. Drug Metab Dispos 19:729-734.
11. Hooijberg JH, Broxterman HJ, Kool M, Assaraf YG, Peters GJ, Noordhuis P, Scheper RJ, Borst P, Pinedo HM and Jansen G (1999) Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2. Cancer Res 59:2532-2535.
12. Jackson RC (1984) Biological effects of folic acid antagonists with antineoplastic activity. Pharmacol Ther 25:61-82.
13. Kepka L, De LA, Ribrag V, Gachot B, Blot F, Theodore C, Bonnay M, Korenbaum C and Nitenberg G (1998) Successful rescue in a patient with high dose methotrexate-induced nephrotoxicity and acute renal failure. Leuk Lymphoma 29:205-209.
14. Li L, Lee TK, Meier PJ and Ballatori N (1998) Identification of glutathione as a driving force and leukotriene C4 as a substrate for oatp1, the hepatic sinusoidal organic solute transporter. J Biol Chem 273:16184-16191.
15. Masuda S, Ibaramoto K, Takeuchi A, Saito H, Hashimoto Y and Inui K (1999a) Cloning and functional characterization of a new multispecific organic anion transporter, OAT-K2, in rat kidney. Mol Pharmacol 55:743-752.
16. Masuda S, Saito H, Nonoguchi H, Tomita K and Inui K (1997) mRNA distribution and membrane localization of the OAT-K1 organic anion transporter in rat renal tubules. FEBS Lett 407:127-131.
17. Masuda S, Takeuchi A, Saito H, Hashimoto Y and Inui K (1999b) Functional analysis of rat renal organic anion transporter OAT-K1: Bidirectional methotrexate transport in apical membrane. FEBS Lett 459:128-132.
18. Ohoka K, Takano M, Okano T, Maeda S, Inui K and Hori R (1993) p-Aminohippurate transport in rat renal brush-border membranes: A potential-sensitive transport system and an anion exchanger. Biol Pharm Bull 16:395-401.
19. Saito H, Masuda S and Inui K (1996) Cloning and functional characterization of a novel rat organic anion transporter mediating basolateral uptake of methotrexate in the kidney. J Biol Chem 271:20719-20725.
20. 1. Am J Physiol 262:C59-C66.
21. Scheufler E, Zetler G and Iven H (1981) Pharmacokinetics and organ distribution of methotrexate in the rat. Pharmacology 23:75-81.
22. Schilsky RL and Ratain MJ (1990) Clinical pharmacokinetics of high-dose leucovorin calcium after intravenous and oral administration. J Natl Cancer Inst 82:1411-1415.
23. Sekine T, Cha SH, Tsuda M, Apiwattanakul N, Nakajima N, Kanai Y and Endou H (1998) Identification of multispecific organic anion transporter 2 expressed pre-dominantly in the liver. FEBS Lett 429:179-182.
24. Sekine T, Watanabe N, Hosoyamada M, Kanai Y and Endou H (1997) Expression cloning and characterization of a novel multispecific organic anion transporter. J Biol Chem 272:18526-18529.
25. Shi X, Bai S, Ford AC, Burk RD, Jacquemin E, Hagenbuch B, Meier PJ and Wolkoff AW (1995) Stable inducible expression of a functional rat liver organic anion transport protein in HeLa cells. J Biol Chem 270:25591-25595.
26. Twelves CJ (1986) Folinic acid rescue and methotrexate toxicity. Lancet 1:737.